In addition to Fer-1, other types of ferroptosis inhibitors, lipoxstatin-1 and IASPP (an inhibitor of p53 transcriptional activity), were found to alleviate the ischemia-reperfusion-induced acute lung injury via inhibiting ferroptosis [37, 38]. The gene discussed is TP53; the disease is injury.